XAV-939

N/A

Report date: 2022/10/23 08:59:24
NME

Base Information

Drug NameXAV-939
Drug Alias NameXAV-939
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTankyrase-1 inhibitorsTankyrase-2 inhibitorsWnt signalling pathway inhibitors
TargetsTankyrase-1Tankyrase-2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovartis Pharma Ag
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A